thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination , claim researchers
it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow
the new therapy targets both the oestrogen - sensitive cells and the remaining cancer stem cells ( pictured ) at the same time â interestingly , dr clarke âs team has also shown that this combination of drugs reduces the number of cancer stem cells in secondary breast cancer samples